High doses of some statins may provide cancer protection

05/16/2008 | Reuters

A new study found people who took high doses of statins that are lipophilic, or soluble in fats -- such as Lipitor, Zocor and Mevacor -- had a 25% lower risk of cancer than those who did not use the cholesterol-lowering medications. People taking a lower dose reduced their cancer risk by 11%.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT